ALL-CAUSE TREATMENT DISCONTINUATION FOR OLANZAPINE COMPARED TO OTHER ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA: A META-ANALYSIS

被引：0
|
作者：
Soares-Weiser, K. [1 ]
Bechard-Evans, L. [1 ]
Lawson, A. H. [2 ]
Davis, J. [3 ]
Ascher-Svanum, H. [2 ]
机构：
[1] Enhance Reviews Ltd, London, England
[2] Eli Lilly & Co, Indianapolis, IN 46285 USA
[3] Univ Illinois, Chicago, IL USA
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)72510-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A106 / A106
页数：1
相关论文
共 50 条
  • [41] BENEFITS AND HARMS OF ANTIPSYCHOTICS IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Hagi, Katsuhiko
    Nosaka, Tadashi
    Pikalov, Andrei
    SCHIZOPHRENIA BULLETIN, 2020, 46 : S242 - S242
  • [42] A NETWORK META-ANALYSIS TO COMPARE THE EFFICACY AND SAFETY OF ANTIPSYCHOTICS AS MAINTENANCE TREATMENT FOR PATIENTS WITH SCHIZOPHRENIA
    Millier, A.
    Zineddine, O.
    Zhou, J.
    Aballea, S.
    Taieb, V
    Toumi, M.
    VALUE IN HEALTH, 2017, 20 (09) : A709 - A709
  • [43] Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia A Network Meta-analysis
    Samara, Myrto T.
    Dold, Markus
    Gianatsi, Myrsini
    Nikolakopoulou, Adriani
    Helfer, Bartosz
    Salanti, Georgia
    Leucht, Stefan
    JAMA PSYCHIATRY, 2016, 73 (03) : 199 - 210
  • [44] ANTIPSYCHOTICS EFFICACY IN TREATMENT OF SCHIZOPHRENIA NEGATIVE SYMPTOMS: META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
    Darba, J.
    Minoves, A.
    Rojo, E.
    Jimenez, F.
    Rejas, J.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [45] Benefits and harms of antipsychotics in the treatment of children and adolescents with schizophrenia: A systematic review and meta-analysis
    Hagi, K.
    Nosaka, T.
    Pikalov, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S79 - S80
  • [46] ANTIPSYCHOTICS EFFICACY IN TREATMENT OF SCHIZOPHRENIA NEGATIVE SYMPTOMS: META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
    Darba, J.
    Minoves, A.
    Rojo, E.
    Jimenez, F.
    Rejas, J.
    EUROPEAN PSYCHIATRY, 2009, 24
  • [47] A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia
    Dong, Shimeng
    Schneider-Thoma, Johannes
    Bighelli, Irene
    Siafis, Spyridon
    Wang, Dongfang
    Burschinski, Angelika
    Schestag, Kristina
    Samara, Myrto
    Leucht, Stefan
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2024, 274 (04) : 917 - 928
  • [48] Benefits and Harms of Antipsychotics in the Treatment of Children and Adolescents With Schizophrenia: A Systematic Review and Meta-Analysis
    Hagi, Katsuhiko
    Nosaka, Tadashi
    Pikalov, Andrei
    BIOLOGICAL PSYCHIATRY, 2020, 87 (09) : S369 - S369
  • [49] Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
    Kishi, Taro
    Ikuta, Toshikazu
    Matsunaga, Shinji
    Matsuda, Yuki
    Oya, Kazuto
    Iwata, Nakao
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2017, 13 : 1281 - 1301
  • [50] BMI and all-cause mortality in older adults: a meta-analysis
    Winter, Jane E.
    MacInnis, Robert J.
    Wattanapenpaiboon, Naiyana
    Nowson, Caryl A.
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2014, 99 (04): : 875 - 890
12345